167 related articles for article (PubMed ID: 15585086)
21. Antigen-specific NK cell memory in rhesus macaques.
Reeves RK; Li H; Jost S; Blass E; Li H; Schafer JL; Varner V; Manickam C; Eslamizar L; Altfeld M; von Andrian UH; Barouch DH
Nat Immunol; 2015 Sep; 16(9):927-32. PubMed ID: 26193080
[TBL] [Abstract][Full Text] [Related]
22. Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates.
Moss B; Carroll MW; Wyatt LS; Bennink JR; Hirsch VM; Goldstein S; Elkins WR; Fuerst TR; Lifson JD; Piatak M; Restifo NP; Overwijk W; Chamberlain R; Rosenberg SA; Sutter G
Adv Exp Med Biol; 1996; 397():7-13. PubMed ID: 8718576
[TBL] [Abstract][Full Text] [Related]
23. Flt3 agonist enhances immunogenicity of arenavirus vector-based simian immunodeficiency virus vaccine in macaques.
Boopathy AV; Nekkalapudi A; Sung J; Schulha S; Jin D; Sharma B; Ng S; Lu S; Wimmer R; Suthram S; Ahmadi-Erber S; Lauterbach H; Orlinger KK; Hung M; Carr B; Callebaut C; Geleziunas R; Kuhne M; Schmidt S; Falkard B
J Virol; 2024 Jun; ():e0029424. PubMed ID: 38829139
[TBL] [Abstract][Full Text] [Related]
24. Optimization and qualification of an 8-color intracellular cytokine staining assay for quantifying T cell responses in rhesus macaques for pre-clinical vaccine studies.
Donaldson MM; Kao SF; Eslamizar L; Gee C; Koopman G; Lifton M; Schmitz JE; Sylwester AW; Wilson A; Hawkins N; Self SG; Roederer M; Foulds KE
J Immunol Methods; 2012 Dec; 386(1-2):10-21. PubMed ID: 22955212
[TBL] [Abstract][Full Text] [Related]
25. Baculovirus vectors elicit antigen-specific immune responses in mice.
Facciabene A; Aurisicchio L; La Monica N
J Virol; 2004 Aug; 78(16):8663-72. PubMed ID: 15280475
[TBL] [Abstract][Full Text] [Related]
26. Highly Attenuated Infection With a Vpr-Deleted Molecular Clone of Human Immunodeficiency Virus-1.
Ali A; Ng HL; Blankson JN; Burton DR; Buckheit RW; Moldt B; Fulcher JA; Ibarrondo FJ; Anton PA; Yang OO
J Infect Dis; 2018 Sep; 218(9):1447-1452. PubMed ID: 29878133
[TBL] [Abstract][Full Text] [Related]
27. DCs for HIV vaccine?
Nat Rev Microbiol; 2007 Mar; 5(3):172. PubMed ID: 17310536
[No Abstract] [Full Text] [Related]
28. Human cytomegalovirus-vectored vaccines against HIV.
Abad-Fernandez M; Goonetilleke N
Curr Opin HIV AIDS; 2019 Mar; 14(2):137-142. PubMed ID: 30562176
[TBL] [Abstract][Full Text] [Related]
29. Rhesus macaques show increased resistance to repeated SHIV intrarectal exposure following a heterologous regimen of rVSV vector vaccine expressing HIV antigen.
Jelinski J; Kowatsch MM; Lafrance MA; Berger A; Pedersen J; Azizi H; Li Y; Scholte F; Gomez A; Hollett N; Le T; Wade M; Fausther-Bovendo H; de La Vega MA; Babuadze G; Xiii A; Lamarre C; Racine T; Kang CY; Yao XJ; Alter G; Arts E; Fowke KR; Kobinger GP
Emerg Microbes Infect; 2023 Dec; 12(2):2251595. PubMed ID: 37649434
[TBL] [Abstract][Full Text] [Related]
30. Live attenuated HIV vaccines: predicting the tradeoff between efficacy and safety.
Blower SM; Koelle K; Kirschner DE; Mills J
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3618-23. PubMed ID: 11248127
[TBL] [Abstract][Full Text] [Related]
31. AIDS vaccine: new ideas from old approaches.
Beale AJ
J R Soc Med; 2003 Jul; 96(7):347-8. PubMed ID: 12835449
[No Abstract] [Full Text] [Related]
32. Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques.
Berger A; Pedersen J; Kowatsch MM; Scholte F; Lafrance MA; Azizi H; Li Y; Gomez A; Wade M; Fausther-Bovendo H; de La Vega MA; Jelinski J; Babuadze G; Nepveu-Traversy ME; Lamarre C; Racine T; Kang CY; Gaillet B; Garnier A; Gilbert R; Kamen A; Yao XJ; Fowke KR; Arts E; Kobinger G
Vaccines (Basel); 2024 Mar; 12(4):. PubMed ID: 38675751
[TBL] [Abstract][Full Text] [Related]
33. Response to HIV-1 gp160-carrying recombinant virus HSV-1 and HIV-1 VLP combined vaccine in BALB/c mice.
Zhang B; Mao H; Zhu H; Guo J; Zhou P; Ma Z
Front Microbiol; 2023; 14():1136664. PubMed ID: 37007461
[TBL] [Abstract][Full Text] [Related]
34. A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2.
Kim GN; Choi JA; Wu K; Saeedian N; Yang E; Park H; Woo SJ; Lim G; Kim SG; Eo SK; Jeong HW; Kim T; Chang JH; Seo SH; Kim NH; Choi E; Choo S; Lee S; Winterborn A; Li Y; Parham K; Donovan JM; Fenton B; Dikeakos JD; Dekaban GA; Haeryfar SMM; Troyer RM; Arts EJ; Barr SD; Song M; Kang CY
PLoS Pathog; 2021 Dec; 17(12):e1010092. PubMed ID: 34914812
[TBL] [Abstract][Full Text] [Related]
35. Viral Vectors for the Induction of Broadly Neutralizing Antibodies against HIV.
Wilmschen S; Schmitz JE; Kimpel J
Vaccines (Basel); 2019 Sep; 7(3):. PubMed ID: 31546894
[TBL] [Abstract][Full Text] [Related]
36. Mucosal Vaccine Approaches for Prevention of HIV and SIV Transmission.
Kozlowski PA; Aldovini A
Curr Immunol Rev; 2019; 15(1):102-122. PubMed ID: 31452652
[TBL] [Abstract][Full Text] [Related]
37. First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090).
Fuchs JD; Frank I; Elizaga ML; Allen M; Frahm N; Kochar N; Li S; Edupuganti S; Kalams SA; Tomaras GD; Sheets R; Pensiero M; Tremblay MA; Higgins TJ; Latham T; Egan MA; Clarke DK; Eldridge JH; ; Mulligan M; Rouphael N; Estep S; Rybczyk K; Dunbar D; Buchbinder S; Wagner T; Isbell R; Chinnell V; Bae J; Escamilla G; Tseng J; Fair R; Ramirez S; Broder G; Briesemeister L; Ferrara A
Open Forum Infect Dis; 2015 Sep; 2(3):ofv082. PubMed ID: 26199949
[TBL] [Abstract][Full Text] [Related]
38. Creation of matrix protein gene variants of two serotypes of vesicular stomatitis virus as prime-boost vaccine vectors.
Kim GN; Wu K; Hong JP; Awamleh Z; Kang CY
J Virol; 2015 Jun; 89(12):6338-51. PubMed ID: 25855732
[TBL] [Abstract][Full Text] [Related]
39. Recombinant rubella vectors elicit SIV Gag-specific T cell responses with cytotoxic potential in rhesus macaques.
Rosati M; Alicea C; Kulkarni V; Virnik K; Hockenbury M; Sardesai NY; Pavlakis GN; Valentin A; Berkower I; Felber BK
Vaccine; 2015 Apr; 33(18):2167-74. PubMed ID: 25802183
[TBL] [Abstract][Full Text] [Related]
40. A novel, live-attenuated vesicular stomatitis virus vector displaying conformationally intact, functional HIV-1 envelope trimers that elicits potent cellular and humoral responses in mice.
Rabinovich S; Powell RL; Lindsay RW; Yuan M; Carpov A; Wilson A; Lopez M; Coleman JW; Wagner D; Sharma P; Kemelman M; Wright KJ; Seabrook JP; Arendt H; Martinez J; DeStefano J; Chiuchiolo MJ; Parks CL
PLoS One; 2014; 9(9):e106597. PubMed ID: 25215861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
